None listed
Conditions
Interventions
None listed
Sponsors
SOUSEIKAI Fukuoka Mirai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, A Japanese male/ female subject who gives written consent to the study.
Exclusion criteria
Exclusion criteria: 1, A subject whose blood is difficult to collect. 2, A subject who the investigators think is not appropriate to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Polymorphism (CYP2C9, CYP2C19, CYP2D6) | — |
Countries
Japan
Contacts
Public ContactYukie Matsuzaki
SOUSEIKAI Fukuoka Mirai Hospital Clinical Research Center
Outcome results
None listed